Chris Erdman
Investor Relations Contact chez MORPHIC HOLDING, INC.
Profil
Chris Erdman is currently the SVP-Investor Relations & Corporate Communications at Morphic Holding, Inc. Prior to this, he was the VP-Investor Relations & External Affairs at CRISPR Therapeutics AG from 2017 to 2018.
From 2004 to 2017, he served as the Managing Partner at MacDougall Advisors, Inc. Mr. Erdman completed his undergraduate degree at Hobart & William Smith Colleges and his graduate degree at Boston University School of Public Health.
Postes actifs de Chris Erdman
| Sociétés | Poste | Début |
|---|---|---|
| MORPHIC HOLDING, INC. | Investor Relations Contact | 01/09/2019 |
Anciens postes connus de Chris Erdman
| Sociétés | Poste | Fin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Investor Relations Contact | 01/01/2018 |
MacDougall Advisors, Inc.
 MacDougall Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services MacDougall Advisors, Inc. provides strategic communication services for the life sciences industry. The company was founded by Kari Watson and Doug E. MacDougall in 2002 and is headquartered in Natick, MA. | Corporate Officer/Principal | 01/01/2017 |
Formation de Chris Erdman
| Boston University School of Public Health | Graduate Degree |
| Hobart & William Smith Colleges | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
MacDougall Advisors, Inc.
MacDougall Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services MacDougall Advisors, Inc. provides strategic communication services for the life sciences industry. The company was founded by Kari Watson and Doug E. MacDougall in 2002 and is headquartered in Natick, MA. | Commercial Services |